心脏选择性药物治疗冠心病的临床效果评价

Evaluation of Clinical Effect of Cardiac Selective Medicine in Treatment of Coronary Heart Disease

目的在冠心病患者治疗过程中应用心脏选择性药物治疗,评价临床效果。方法本次探究需要在我院2015年8月-2016年8月所收治的冠心病患者中利用自愿参与原则选取54例作为样本人群,按照随机数字表法对54例患者实行均分,2组患者分别命名为研究组和参照组,每组27例患者。在参照组患者药物治疗过程中应用常规治疗,在研究组患者药物治疗过程中应用常规治疗+美托洛尔治疗,将2组患者实行不同药物治疗后得到的组间数据进行统计学分析。结果:研究组患者的临床总有效率、发作持续时间、发作频率、LVEDD、LVESD、LVEEF、HR、DBP、SBP均显著性更优,与参照组患者对比,组间数据对比存在统计学意义(P<0.05)。结论在冠心病患者治疗过程中应用心脏选择性药物治疗的临床效果较为理想,可显著改善患者的临床症状以及改善患者的各项临床指标,值得临床借鉴。

Objective to evaluate clinical effect of cardiac selective medicine in treatment of patients with coronary heart disease(CHD). Methods in the study, choose 54 cases CHD patients treated in our hospital from August 2015 August 2016 by voluntary principle as samples, randomly divide them into research and control group on average, 27 cases in each. Control group was treated with routine treatment during during medicaiton treatment, and research group with routine treatment+metoprolol. Carry on statistical analysis for data between groups after different medication treatment. Results clinical total effective rate, onset duration, frequency, LVEDD, LVESD, LVEEF, HR, DBP and SBP of research group was significantly higher than control group, data comparison between groups showed statistical significance(P<0.05). Conclusion cardiac selective medicine has ideal linical effect for coronary heart disease patients during treatment, which can significantly improve clinical symptoms and patient's clinical indicators, and is worthy of clinical